Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5032751 | 0.87 | FDPS (0.39) | FDPSALDH1A1 | |
| SCHEMBL27317051 | 0.84 | FDPS (0.31) | FDPS | |
| SCHEMBL321606 | 0.79 | TSHR (0.33) | — | |
| SCHEMBL28639718 | 0.79 | FDPS (0.35) | FDPS | |
| SCHEMBL8899907 | 0.77 | FDPS (0.34) | FDPSALDH1A1 | |
| Water SCHEMBL9098196 | 0.76 | TSHR (0.31) | — | |
| SCHEMBL25354373 | 0.75 | FDPS (0.36) | FDPSALDH1A1 | |
| SCHEMBL29622322 | 0.73 | TSHR (0.38) | ALDH1A1 | |
| SCHEMBL28926749 | 0.73 | FDPS (0.39) | FDPSALDH1A1 | |
| SCHEMBL28515501 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116478155-B | Preparation method of grapiprant and intermediate thereof | 洛阳惠中兽药有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-20100048920-A1 | Preparation of (+)-Catechin, (-)-Epicatechin, (-)-Catechin, and (+)-Epicatechin and Their 5,7,3',4'-Tetra-O-Benzyl Analogues | MARS, INCORPORATED (US) | 2010-02-25 | — | — | US | claimed |
| EP-1973870-A1 | METHOD FOR PRODUCING LIQUID, STORAGE-STABLE ORGANIC ISOCYANATES COMPRISING CARBODIIMIDE AND/OR URETONIMINE GROUPS | Bayer MaterialScience AG (DE) | 2008-10-01 | — | — | EP | claimed |
| EP-1896443-A1 | PREPARATION OF (+)-CATECHIN, (-)-EPICATECHIN, (-)-CATECHIN, (+)-EPICATECHIN, AND THEIR 5,7,3',4'-TETRA-O-BENZYL ANALOGUES | MARS, INCORPORATED (US) | 2008-03-12 | — | — | EP | claimed |
| WO-2007076999-A1 | METHOD FOR PRODUCING LIQUID, STORAGE-STABLE ORGANIC ISOCYANATES COMPRISING CARBODIIMIDE AND/OR URETONIMINE GROUPS | BAYER MATERIALSCIENCE AG (DE) | 2007-07-12 | — | — | WO | claimed |
| WO-2007002877-A1 | PREPARATION OF (+)-CATECHIN, (-)-EPICATECHIN, (-)-CATECHIN, (+)-EPICATECHIN, AND THEIR 5,7,3',4'-TETRA-O-BENZYL ANALOGUES | MARS, INCORPORATED (US) | 2007-01-04 | — | — | WO | claimed |
| US-6596866-B2 | Reacting semicarbazide dihydrochloride derivative with triethyl orthopropionate using trimethylsilyl chloride and hydrochloric acid; salt formation, cyclization | BRANTFORD CHEMICALS INC. (CA) | 2003-07-22 | — | — | US | claimed |
| US-20030078423-A1 | Process for the preparation of nefazodone hydrochloride | BRANTFORD CHEMICALS INC. | 2003-04-24 | — | — | US | claimed |
| EP-0882106-B1 | Coating composition comprising a bicyclo- or spiro-orthoester-functional compound | AKZO NOBEL NV (NL) | 2000-08-09 | — | — | EP | claimed |
| EP-0641304-B1 | STEREO-SELECTIVE SYNTHESIS OF 2-ARYL-PROPIONIC ACIDS OF HIGH OPTICAL PURITY BY USING CHIRAL OXAZOLINES | CHEMISCH BIOTECHNOLOGISCHE LAB (DE) | 1998-04-08 | — | — | EP | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12569566-B2 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | AMBRX, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| EP-3883927-B1 | AMBER ODORANT | FIRMENICH & CIE (CH) | 2025-10-01 | — | — | EP | disclosed |
| US-12139469-B2 | Amber odorant | FIRMENICH SA (CH) | 2024-11-12 | — | — | US | disclosed |
| US-20230302150-A1 | ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF | AMBRX, INC. (US) | 2023-09-28 | — | — | US | disclosed |
| US-4044016-A | ANTICONVULSANTS, SEDATIVES, MUSCLE RELAXANTS | HOFFMANN-LA ROCHE INC. (US) | 1977-08-23 | — | — | US | disclosed |
| US-4028408-A | Novel preparation of trifluoromethylthioacetic acid | SMITHKLINE CORPORATION (US) | 1977-06-07 | — | — | US | disclosed |
| US-3992422-A | Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes | SCHERING CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
| US-3970664-A | ANTICONVULSANT, MUSCLE RELAXANT, SEDATIVE | HOFFMANN-LA ROCHE INC. (US) | 1976-07-20 | — | — | US | disclosed |
| US-3954728-A | ANTICONVULSANTS, MUSCLE RELAXANTS, SEDATIVES | HOFFMAN-LA ROCHE INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078423-A1 | Process for the preparation of nefazodone hydrochloride | TET3, SI, OPRK1 | FDPS 1925/4885ALDH1A1 1202/4885 |
| US-20230302150-A1 | ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF | TLR3, TLR1, TLR9 | FDPS 4342/4885ALDH1A1 2172/4885 |
| US-20100048920-A1 | Preparation of (+)-Catechin, (-)-Epicatechin, (-)-Catechin, and (+)-Epicatechin and Their 5,7,3',4'-Tetra-O-Benzyl Analogues | HAAO, TES, HPD | FDPS 3039/4885ALDH1A1 442/4885 |
| US-12569566-B2 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | TLR3, TLR2, TLR1 | FDPS 4179/4885ALDH1A1 1721/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | FDPS 1946/4885ALDH1A1 804/4885 |
| US-12139469-B2 | Amber odorant | OPRM1, TRPA1, PYM1 | FDPS 2923/4885ALDH1A1 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.